Natural products with γ-pyrone scaffold from Streptomyces

Area of Science:

• Microbiology
• Natural Product Chemistry
• Medicinal Chemistry

Background:

• Streptomyces species are prolific producers of diverse bioactive natural products, including polyketides, terpenoids, lanthipeptides, and non-ribosomal peptides.
• Many natural products from Streptomyces contain a gamma-pyrone ring, a structural motif associated with various bioactivities.
• These compounds are isolated from diverse environments, including soil and marine ecosystems.

Purpose of the Study:

• To review and summarize gamma-pyrone-containing natural products isolated from Streptomyces species.
• To focus on the structural diversity and reported bioactivities of these compounds.
• To highlight the potential of Streptomyces as a source for novel therapeutic agents.

Main Methods:

• Literature review of scientific publications on natural products from Streptomyces.
• Analysis of chemical structures of gamma-pyrone containing compounds.
• Compilation and categorization of reported bioactivities, including antinematodal, cytotoxicity, antibacterial, anticancer, antifungal, antimalarial, and TRPV1 blocking activities.

Main Results:

• Identified several classes of gamma-pyrone compounds from Streptomyces, including nitrophenyl-γ-pyrones (e.g., aureothin, spectinabilin), anthra-γ-pyrones (e.g., shellmycin A-D, pluramycin family), and xanthones (e.g., albofungin, cervinomycins).
• Documented a wide spectrum of bioactivities associated with these compounds, such as antinematodal, cytotoxicity, antibacterial, anticancer, antibiofilm, antimacrofouling, antifungal, antimalarial, and TRPV1 antagonism.
• Highlighted specific examples like aureothin, spectinabilin, shellmycin A-D, kidamycin, rubiflavin, albofungin, and cervinomycins, detailing their respective activities.

Conclusions:

• Streptomyces species are a rich source of structurally diverse gamma-pyrone natural products with significant and varied bioactivities.
• The identified compounds demonstrate potential for development into therapeutic agents for various diseases, including cancer, bacterial infections, and parasitic infections.
• Continued exploration of Streptomyces is expected to yield an expanding repertoire of novel gamma-pyrone compounds with promising pharmacological properties.